Oncologic impact of statin use on patients treated with hepatectomy for intrahepatic cholangiocarcinoma
Jae Hwan Jeong, Dai Hoon Han, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Sung Hyun Kim, Sangheun Lee
IF 3.4Hepatology Research
초록
Statin therapy may be a potentially favorable medication for patients undergoing hepatectomy for ICC. However, further evaluation of its clinical benefits is required, and additional studies are recommended.